Effect of Progressive Exercise on Renal Transplant Patients

Fatigue Clinical Trial

Official title:

The Effects of Progressive Exercises on the Vital Signs and Fatigue in Patients With Renal Transplant

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05876507
• Other study ID #: KA22/239
• Status: Recruiting
• Phase: N/A
• Start date: February 13, 2023
• Est. completion date: June 15, 2023

Study information

• Verified date: May 2023
• Source: Baskent University
• Contact: Seyda Uzun Yagiz, RN
• Phone: +905392791581
• Email: seydauzun97[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this interventional study is to determine the effect of progressive relaxation exercises on the vital signs and fatigue levels of patients with renal transplantation.

Description:

Renal transplant patients experience intense level of fatigue as well as vital sign problems due to treatment protocol. This research is designed to determine the effect of progressive relaxation exercises on vital signs and fatigue level of patients with renal transplantation.

In this study, the participants will be randomized in a single blind manner (participant) to either intervention (4 week exercise program) or control (routine care) groups.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 52
• Est. completion date: June 15, 2023
• Est. primary completion date: May 15, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients underwent renal transplant within one year from the beginning of the study

• Patients having no communication problems

• Patients having a smart phone either own or o family member

Exclusion Criteria:

• Patients having musculoskeletal, cardiopulmonary, or psychiatric disorders

Related Conditions & MeSH terms

• Fatigue
• Nursing
• Renal Transplant
• Vital Signs

Intervention

Behavioral:
• Progressive relaxation exercise
Progressive relaxation exercises will take 25-30 minutes of patients daily.

Locations

Country	Name	City	State
Turkey	Baskent University Hospital	Ankara	Çankaya

Sponsors (1)

Lead Sponsor	Collaborator
Baskent University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Systolic and diastolic blood pressure	Maintaining or normalizing systolic and blood pressure within normal range (systolic: 90-140 mmHg; diastolic 60-90 mmHg)	Change fron baseline at 4th week
Primary	fatigue level	Fatigue Severity Scale is a valid and 7-point Likert type scale. Possible scores range from 9-63. Higher scores indicate high level of fatigue. A score of 36 points or over indicates severe fatigue (Change= Lower score from the scale at the end of intervention compared to baseline).	Change from baseline at 4th week
Primary	Heart rate	Maintaining or normalizing heart rate within normal range (60 to 100 bpm)	Change from baseline at 4th week
Primary	Respiratory rate	Maintaining or normalizing respiratory rate within normal range (12-20 breath per minute)	Change from baseline at 4th week
Primary	Body temperature	Maintaining or normalizing body temperature within normal range (36-37 C° in tympanic measurement)	Change from baseline at 4th week
Primary	Oxygen saturation	Maintaining or normalizing oxygen saturation within normal range (between 95%-100% by pulse oximetry)	Change from baseline at 4th week